V-Vision — Seed

V-Vision's first seed round was backed by the San Sebastián VC fund EASO Ventures. It paid for the market launch of Dicopt, its VR dichoptic therapy for amblyopia. The amount was not disclosed. The sources only say the round closed 'in the first months of 2021', so the date is set to January 2021 as a placeholder. The Mercantile Registry records a matching capital increase on 17 June 2021. The deal was reported publicly in February 2022. Earlier, in October 2020, V-Vision was a winner of BerriUp's 11th acceleration call. Databases also list Startup Wise Guys, BIC Gipuzkoa and the Ekin+ programme as backers, but none of them was announced as a funding round. A further small capital increase was registered in September 2023, but no round was announced for it.